On August 28, 2019 ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing cancer treatments that address mechanisms of therapeutic resistance, reported that it will be participating in Citi’s 14th Annual Biotech Conference in Boston (Press release, ORIC Pharmaceuticals, AUG 28, 2019, View Source [SID1234539100]). On Wednesday, September 4, 2019 at 3:45 pm ET, Jacob Chacko, MD, Chief Executive Officer, will participate in a panel discussion entitled, "Emerging Innovators – An Introduction to Biotech Privates."

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!